Cambridge, UK, 30th April 2018 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is pro
Pharmaceutical
Thu, 26/04/2018 - 07:30
London, UK, 26th April 2018 / Sciad Newswire / Oppilotech Ltd, a biopharmaceutical company founded to develop safe, first
Mon, 23/04/2018 - 07:30
Edinburgh, UK, 23rd April 2018 / Sciad Newswire / Synpromics Ltd, the leader in gene control, announces a partnership wit
Wed, 11/04/2018 - 08:00
London, UK, 11th April 2018 / Sciad Newswire / The RSA Group, a leading Life Sciences executive search firm, is increasi
Tue, 20/03/2018 - 10:23
Sciad Communications, the science, tech and health communications consultancy, is pleased to announce its corporate sponsorship of OBN, the membership organisation supporting the UK’s innovative life sciences companies.
Mon, 12/03/2018 - 07:00
Cambridge, UK, 12th March 2018 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is ple
Thu, 08/03/2018 - 11:51
London, Ongar, Cambridge, UK, 8th March 2018 / Sciad Newswire / A new collaboration in the efforts to find a new drug candidate to combat Parkinson’s has been ann
Wed, 07/03/2018 - 07:30
Coventry, UK, 7th March 2018 / Sciad Newswire / Medherant Ltd, a leader in next-generation transdermal drug delivery, is
Tue, 27/02/2018 - 07:30
Newly patented hypergraph data model solidifies Riffyn’s position in the expanding market for linked-data analytics and AI in biotech and pharmaceutical R&D
Mon, 26/02/2018 - 07:30
Prokarium today announced the completion of a $10 million investment round. The round was led by Riyadh Valley Company, followed by Prokarium’s original investor Flerie Invest as well as Korea Investment Partners.